同行导航干预和与急诊室患者的阿片类药物相关不良事件:一项随机临床试验
Kelly M Doran1,2, Alice E Welch3, Kelsey L Kepler3
1Department of Emergency Medicine, NYU Grossman School of Medicine, New York.
JAMA network open
|February 6, 2026
概括
在一个随机试验中,急诊室的同行健康倡导者没有显著减少与阿片类药物相关的不良事件. 这项研究强调了对过量生存者的有效干预措施的需要.
科学领域:
- 公共卫生 公共卫生
- 紧急医疗 紧急医疗
- 药物使用障碍治疗 药物使用障碍治疗
背景情况:
- 紧急服务部门 (ED) 是干预高危过量患者的关键点.
- 同行提供的干预措施对物质使用障碍 (SUD) 的支持有希望,但需要严格的评估.
- 该Relay倡议旨在为ED患者提供非致命的阿片类药物过量后的同行支持.
研究的目的:
- 评估Relay同行健康倡导者 (WA) 计划的有效性,与患有阿片类药物过量患者的标准护理相比.
- 评估同行支持对减少后续阿片类药物相关不良事件的影响.
主要方法:
- 一项随机临床试验在纽约市的四个急救中心进行.
- 在涉及阿片类药物过量后出现的成人患者被招募并随机分配到Relay干预或现场指导护理 (SDC) 中.
- 结果,包括阿片类药物相关的不良事件,被追踪了12个月,使用卫生行政数据和自我报告.
主要成果:
- 在Relay手臂 (3.29事件) 和SDC手臂 (4.10事件) 之间没有发现与阿片类药物相关的不良事件的统计学上显著差异.
- 总体而言,9.7%的参与者在12个月内死亡,其中70.8%的死亡归因于过量服用.
- 继电器计划的参与者报告说,对干预的满意度很高.
结论:
- 与标准护理相比,Relay同行导航器干预没有显示后续阿片类药物相关不良事件的显著减少.
- 调查结果强调,急需采取干预措施,降低高风险人群的死亡率.
- 进一步的研究可能会探索对基于ED的同行干预策略的改进.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
9.2K
07:52Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
Published on: January 29, 2011
17.0K
相关概念视频
Clinical Trials
10.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.8K
Clinical Trials: Overview
5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.1K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.1K
Statistical Software for Data Analysis and Clinical Trials
1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Opioid Receptors: Overview
4.4K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.4K
Emerging Adulthood
715
Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during...
715
